Expert opinion on NSCLC small specimen biomarker testing part 1: tissue collection and management

Penault-Llorca, F., Kerr, K.M., Garrido, P. et al. Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management. Virchows Arch (2022). https://doi.org/10.1007/s00428-022-03343-2

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer

Fairley, J.A., Cheetham, M.H., Patton, S.J. et al. Results of a worldwide external quality assessment of cfDNA testing in lung Cancer. BMC Cancer 22, 759 (2022). https://doi.org/10.1186/s12885-022-09849-x

An Independent Assessment of a Commercial Clinical Interpretation Software Indicates That Software Can Mitigate Variation in Human Assessment.

Fairley, J.A.; Deans, Z.C.; Treacy, R.J.L.; Grieg, E.; Bungartz, K.; Burton, R.; Hayes, J.; Elkin, S.K. An Independent Assessment of a Commercial Clinical Interpretation Software Indicates That Software Can Mitigate Variation in Human Assessment. J. Mol. Pathol. 2022, 3, 125–139. https://doi.org/10.3390/jmp3030012

Recommendations for whole genome sequencing in diagnostics for rare diseases.

Souche E, Beltran S, Brosens E, Belmont JW, Fossum M, Riess O, Gilissen C, Ardeshirdavani A, Houge G, van Gijn M, Clayton-Smith J, Synofzik M, de Leeuw N, Deans ZC, Dincer Y, Eck SH, van der Crabben S, Balasubramanian M, Graessner H, Sturm M, Firth H, Ferlini A, Nabbout R, De Baere E, Liehr T, Macek M, Matthijs G, Scheffer H, Bauer P, Yntema HG, Weiss MM. Recommendations for whole genome sequencing in diagnostics for rare diseases. Eur J Hum Genet. 2022 May 16. https://doi.org/10.1038/s41431-022-01113-x

Lessons from the 2019 GenQA preimplantation genetic testing external quality assessments for aneuploidies and structural chromosomal abnormalities. [POSTER]

M Sales, F Khawaja, R Hastings, A Birick, D Kubicek, E Coonen, L Rodrigo Vivo, S Knebel, ZC Deans. 2022 Preimplantation Genetic Diagnosis International Society (PGDIS), Berlin, Germany.

VIEW MORE ITEMS